Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search:
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
Showing
101
-
120
of
214
Search:
''
,
query time: 0.26s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
101
CADTH Canadian drug expert committee recommendation: Cyclosporine 0.1% (Verkazia -- Santen Canada Inc.) : indication : treatment of severe vernal keratoconjunctivitis in children f...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
102
CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) : indication : diabetic macular edema
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
103
CADTH Canadian Drug Expert Committee recommendation (final): Sebelipase alfa (Kanuma -- Alexion Pharmaceuticals, Inc.) indication : lysosomal acid lipase deficiency
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
104
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...
Published 2019
CADTH
Read Now
105
CADTH Canadian Drug Expert Committee recommendation: Efinaconazole (Jublia -- Bausch Health, Canada Inc.) : indication : for the topical treatment of mild to moderate onychomycosis...
Published 2019
CADTH
Read Now
106
CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
107
CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease
Published 2018
CADTH
Read Now
108
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2019
CADTH
Read Now
109
CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection
Published 2016
Canadian Agency for Drugs and Technologies in Health
Read Now
110
CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) : indication : diabetic macular edema
Published 2019
Canadian Agency for Drugs and Technologies in Health
Read Now
111
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...
Published 2019
CADTH
Read Now
112
CADTH Canadian Drug Expert Committee recommendation: Levodopa/carbidopa intestinal gel (Duodopa -- Abbvie Corporation) : indication : Parkinson's disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
113
CADTH Canadian drug expert committee recommendation: Ustekinumab (Stelara/Stelara I.V. -- Janssen Inc.) : indication : for the treatment of adult patients with moderately to severe...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Read Now
114
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Read Now
115
CADTH Canadian Drug Expert Committee recommendation: Teduglutide (Revestive -- Shire Pharmaceuticals Ireland Limited) : indication: treatment of adults and pediatric patients 1 yea...
Published 2019
CADTH
Read Now
116
CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.) : indication : coronary artery disease with or without peripheral artery disease
Published 2018
CADTH
Read Now
117
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Read Now
118
CADTH Canadian Drug Expert Committee recommendation: Cerliponase Alfa (Brineura -- Biomarin Pharmaceutical [Canada] Inc.) : indication : for the treatment of neuronal ceroid lipofu...
Published 2019
CADTH
Read Now
119
CADTH Canadian Drug Expert Committee recommendation: Efinaconazole (Jublia -- Bausch Health, Canada Inc.) : indication : for the topical treatment of mild to moderate onychomycosis...
Published 2019
CADTH
Read Now
120
CADTH Canadian Drug Expert Committee recommendation: Risankizumab (Skyrizi -- Abbvie) : indication : adult patients with moderate to severe plaque psoriasis
Published 2019
CADTH
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
610 - Medicine & health
201
330 - Economics
113
140 - Specific philosophical schools
24
700 - The arts; fine & decorative arts
17
580 - Plants (Botany)
3
800 - Literature & rhetoric
2
more ...
380 - Commerce, communications & transportation
1
see all ...
less ...
Language
English
214
Collection
National Center for Biotechnology Information
214
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
161
Recently Uploaded
Last Month
10
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=6&filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&type=AllFields
Send by Email
×
Loading...